Christian Hametner
Overview
Explore the profile of Christian Hametner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
86
Citations
1128
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Milasing N, Toussaint V, Hametner C, Khuwijitjaru P, Delidovich I
Food Chem
. 2025 Feb;
476:143398.
PMID: 39978005
D-tagatose (Tag) is a rare monosaccharide with health benefits. In this work, catalytic activity of CAPS (pH 10.4), carbonate (pH 10.4), triethylamine (pH 11.2), quinuclidine (pH 11.5), and L-arginine (pH ...
2.
Goyal M, Ospel J, Ganesh A, Dowlatshahi D, Volders D, Mohlenbruch M, et al.
N Engl J Med
. 2025 Feb;
PMID: 39908448
Background: Whether the large effect size of endovascular thrombectomy (EVT) for stroke due to large-vessel occlusion applies to stroke due to medium-vessel occlusion is unclear. Methods: In a multicenter, prospective,...
3.
Barba L, Vollmuth C, Halbgebauer S, Ungethum K, Hametner C, Essig F, et al.
Eur J Neurol
. 2024 Dec;
32(1):e16581.
PMID: 39714176
Background: We aimed to investigate the prognostic role of β-synuclein in comparison to that of neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) for predicting functional outcome after...
4.
Kollikowski A, Pham M, Marz A, Feick J, Vogt M, Xiong Y, et al.
EBioMedicine
. 2024 Apr;
103:105095.
PMID: 38579365
Background: Matrix metalloproteinases (MMPs) are implied in blood-brain barrier degradation and haemorrhagic transformation following ischaemic stroke, but their local relevance in the hyperacute disease phase is unknown. We aimed to...
5.
Seystahl K, Martinez-Majander N, Salerno A, Beyeler M, Erdur H, Marto J, et al.
Neurology
. 2023 Jul;
101(12):e1241-e1255.
PMID: 37463747
Background And Objectives: IV thrombolysis (IVT) for suspected ischemic stroke in patients with intracranial neoplasms is off-label. However, data on risks of intracranial hemorrhage (ICH) are scarce. Methods: In a...
6.
Baumgartner P, Kook L, Altersberger V, Gensicke H, Ardila-Jurado E, Kagi G, et al.
Eur Stroke J
. 2023 Jul;
8(4):966-973.
PMID: 37421135
Background: Retinal artery occlusion (RAO) may lead to irreversible blindness. For acute RAO, intravenous thrombolysis (IVT) can be considered as treatment. However, due to the rarity of RAO, data about...
7.
Traenka C, Lorscheider J, Hametner C, Baumgartner P, Gralla J, Magoni M, et al.
J Stroke
. 2023 Jun;
25(2):272-281.
PMID: 37282374
Background And Purpose: This study aimed to investigate the effect of endovascular treatment (EVT, with or without intravenous thrombolysis [IVT]) versus IVT alone on outcomes in patients with acute ischemic...
8.
Intravenous Thrombolysis 4.5-9 Hours After Stroke Onset: A Cohort Study from the TRISP Collaboration
Altersberger V, Sibolt G, Enz L, Hametner C, Scheitz J, Henon H, et al.
Ann Neurol
. 2023 Apr;
94(2):309-320.
PMID: 37114466
Objective: To investigate the safety and effectiveness of intravenous thrombolysis (IVT) >4.5-9 hours after stroke onset, and the relevance of advanced neuroimaging for patient selection. Methods: Prospective multicenter cohort study...
9.
Altersberger V, Rusche N, Martinez-Majander N, Hametner C, Scheitz J, Henon H, et al.
Stroke
. 2022 Oct;
53(12):3557-3563.
PMID: 36252105
Background: The probability to receive intravenous thrombolysis (IVT) for treatment of acute ischemic stroke declines with increasing age and is consequently the lowest in very elderly patients. Safety concerns likely...
10.
Altersberger V, Enz L, Sibolt G, Hametner C, Nannoni S, Heldner M, et al.
J Neurol
. 2022 May;
269(10):5405-5419.
PMID: 35622132
Objective: To investigate the prognostic value of white blood cell count (WBC) on functional outcome, mortality and bleeding risk in stroke patients treated with intravenous thrombolysis (IVT). Methods: In this...